COOPER COMPANIES, INC.
www.coopercorp.inAI Executive Summary
AI-powered analysis of 10-Q filing content
Cooper Companies recorded a material $325.8 million litigation accrual (net $272.0 million impact for the nine months ended July 31, 2026) related to the LifeGlobal embryo culture media recall, representing a significant reversal from prior 'immaterial' loss estimates as litigation exposure escalated with 140+ lawsuits and 1,500+ claimants. Additionally, an unfavorable UK First-tier Tribunal (FTT) ruling on a legacy Sauflon payroll tax dispute creates potential exposure of up to £71.7 million plus interest, which the company is appealing. Despite these legal headwinds, the company continued aggressive share repurchases, increasing authorization to $3.0 billion in September 2026.
Red Flags Detected (4)
Material litigation accrual of $325.8 million (net $272.0M impact) for LifeGlobal embryo culture media recall, reversing prior assessment that a material loss was not probable
Over 140 lawsuits including 3 putative class actions and 1,500+ claimants tied to embryo loss/viability claims
Adverse UK FTT ruling on Sauflon acquisition-related payroll tax dispute with exposure up to £71.7 million plus accrued interest
1 more red flag detected
Key Takeaways
Litigation reserve of $325.8 million reflects a material shift in legal risk assessment tied to the 2023 LifeGlobal embryo culture media recall
Company continues to face significant unresolved claims (140+ lawsuits, 1,500+ claimants) with potential for losses beyond insurance limits
3 more takeaways
Filing Overview
What This Means
High Risk Filing: This company is showing signs of financial stress or significant operational challenges.
Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.
Quarterly Report: Interim filing with unaudited financial data for the quarter.